Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA)

NAActive, not recruitingINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

April 30, 2023

Study Completion Date

September 30, 2024

Conditions
Breast Cancer
Interventions
PROCEDURE

Immediate IBBR+TiLoop®Bra

Patients will receive immediate implant reconstruction following mastectomy using TiLoop®Bra

PROCEDURE

Immediate-delayed IBBR+TiLoop®Bra

Patients will receive immediate-delayed implant reconstruction following mastectomy using TiLoop®Bra

Trial Locations (11)

110001

The first hospital of China medical university, Shengyang

110801

Liaoning Cancer Hospital & Insitute, Shenyang

200032

Cancer Hospital/ Institute, Fudan University, Shanghai

210029

Jiangsu Province Hospital, Nanjing

266000

The Affiliated Hospital of Qingdao University, Qingdao

310004

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou

310006

Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou

310009

The Second Affiliated Hospital of Zhejiang University, Hangzhou

501120

Sun Yat-sen Memorial Hospital,Sun Yat-sen University, Guangzhou

511400

Guangdong Women and Children Hospital, Guangzhou

050000

Hebei Cancer Hospital, Shijiazhuang

All Listed Sponsors
collaborator

First Hospital of China Medical University

OTHER

collaborator

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

collaborator

The First Affiliated Hospital with Nanjing Medical University

OTHER

collaborator

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

lead

Jiong Wu

OTHER

NCT03589924 - Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA) | Biotech Hunter | Biotech Hunter